1 |
Dupuy J, Larrieu JF, Sutra A and Alvinerie M. Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: Quercetin, Vet Parasitol 2003; 112: 337-347
DOI
ScienceOn
|
2 |
Lamszus K, Kunkel P and Westphal M. Invasion as limitation to antiangiogenic glioma therapy, Acta Neurochir Suppl 2003; 88: 169-177
PUBMED
|
3 |
Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, Shieh CJ, Shiao MS and Chen YJ. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion and metastasis, J Agric Food Chem 2003; 51: 7907-7912
DOI
PUBMED
|
4 |
Moon A and Kim MS. H-ras but not N-ras induces an invasive phenotype in human breast epithelial cells: a role for MMp-2 in the H-ras-induced invasive phenotype, Int J Cancer 2000; 85: 176-181
PUBMED
|
5 |
Doostdar H, Burke MD and Mayer RT. Bioflavonoids: Selective substrated and inhibitors for cytochrome P450 CYP1A and CYP1B1, Toxicology 2000; 144: 31-38
DOI
PUBMED
ScienceOn
|
6 |
Gao K, Henning SM, Niu Y, Youssefian AA, Seeram NP, Xu A and Heber D. The citrus flavonoid naringenin stimulates DNA repair in prostate cancer cells, J Nutr Biochem 2006; 17: 89-95
DOI
ScienceOn
|
7 |
Chambers AF and Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis, J Natl Cancer Inst 1997; 89: 1260-1270
DOI
ScienceOn
|
8 |
Kwon OS, Kim BY, Kim KA, Kim MS, Oh HC, Kim BS, Kim YH and Ahn JS. Effect of the Hesperetin and Naringenin on -induced Activation, Kor J Pharmacogn 2004; 35: 244-249
|
9 |
Jiang Y, Goldberg ID and Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer, Oncogene 2002; 21: 2245-2252
DOI
ScienceOn
|
10 |
Ameer B, Weintraub RA, Johnson JV, Yost RA and Rouseff RL, Flavanone absorption after naringin, hesperidin, and citrus administration, Clin Pharmacol Ther 1996; 60: 34-40
DOI
ScienceOn
|
11 |
De Clerck YA, Darville MI, Eeckhout Y and Rousseau GG. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2), Gene 1994; 139: 185-191
DOI
ScienceOn
|
12 |
Yoon SO, Park SJ, Yoon SY, Yun CH and Chung AS. Sustained production of H2O2 activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway, J Biol Chem 2002; 277: 30271-30282
DOI
ScienceOn
|
13 |
Van Acker FA, Schouten O, Haenen GR, Van der Vijgh WJ and Bast A. Flavonoids can replace a-tocopherol as an antioxidant, FEBS Lett 2000; 473: 145-148
DOI
ScienceOn
|
14 |
Duffy MJ, Maguire TM, Hill A, McDermott E and O’Higgins N. Metalloproteinases:role in breast carcinogenesis, invasion and metastasis, Breast Cancer Res 2000; 2: 252-257
DOI
ScienceOn
|
15 |
Mosmann T. Rapid colorimetric assay for cellular growth and survival : Application of proliferation and cytotoxicity assays, J Immunol Methods 1983; 65: 55-63
DOI
PUBMED
ScienceOn
|
16 |
Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis, Cancer Metastasis Rev 1990; 9: 289-303
DOI
ScienceOn
|
17 |
Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ and Cao J. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP), J Biol Chem 1998; 273: 1216-1222
DOI
ScienceOn
|
18 |
Kanno SI, Tomizawa A, Hiura T, Osanai Y, Shouji A, Ujibe M, Ohtake T, Kimura K and Ishikawa M. Inhibitory Effects of Naringenin on Tumor Growth in Human Cancer Cell Lines and Sarcoma S-180-Implanted Mice, Biol Pharm Bull 2005; 28: 527-530
DOI
ScienceOn
|
19 |
Ruh MF, Zacharewski T, Connor K, Howell J, Chen I and Sage S. Naringenin: A weakly estrogenic bioflavonoid that exhibits antiestrogenic activity, Biochem Pharmacol 1995; 50: 1485-1493
DOI
ScienceOn
|
20 |
Curry JD, Glaser MC and Smith MT. Real-time reverse transcription polymerase chain reaction detection and quantification of t (1;19) (E2A-PBX1) fusion genes associated with leukaemia, Br J Haematol 2001; 115: 826-830
DOI
PUBMED
ScienceOn
|